Beta-Caryophyllene

Structure: the cyclobutane is the point

Beta-caryophyllene is C15H24 at about 204.36 g/mol, a bicyclic sesquiterpene whose unusual feature is a cyclobutane ring fused to a nine-membered carbocycle with a trans-configured endocyclic double bond. That strained, rigid, highly lipophilic shape is why it fits CB2 while resembling nothing in the classical cannabinoid series: it is not a resorcinol, has no phenolic hydroxyl and no alkyl side chain, and so bears no structural relation to THC at all. The atmospheric boiling point is high for a terpene — around 254 to 257 degrees Celsius, above the cannabinoid decarboxylation range — which has a direct practical consequence: beta-caryophyllene survives conditions that destroy monoterpenes, so a concentrate or a long-cured flower that has lost its monoterpenes often retains a relatively enriched caryophyllene share. The epoxide, caryophyllene oxide, forms readily on air exposure and is a separate analyte with separate significance.

Sources: Gertsch J 2008 · Compiled from public compound databases (PubChem 2026* · Russo EB 2011

Selective CB2 agonism — the strongest receptor finding on this shelf animal

Gertsch and colleagues, publishing in PNAS in 2008 under the title "Beta-caryophyllene is a dietary cannabinoid", showed that (E)-beta-caryophyllene binds cannabinoid receptor type 2 with high affinity — reported in the low nanomolar range — and acts there as a full agonist, inhibiting adenylate cyclase and activating downstream CB2 signalling in the sub-micromolar concentration range, while showing no significant activity at CB1. In vivo they reported that oral beta-caryophyllene reduced inflammatory paw oedema in wild-type mice and that the effect was absent in CB2-knockout animals, which is the genetic control that makes the mechanism claim credible rather than merely correlational. This is the cleanest receptor pharmacology of any compound on this shelf: a specific receptor, a nanomolar affinity, functional agonism, a knockout control, and oral activity at a dietary compound. It is the basis for describing beta-caryophyllene as a dietary cannabinoid and for the whole strategy of modulating the CB2 arm of the endocannabinoid system with common culinary and medicinal botanicals rather than with cannabis.

Sources: Gertsch J 2008

CORRECTION to the operator archive: CB2, not CB1

The 2016 Van Kush terpene notes state that caryophyllene "attaches to CB1 receptor". That is not what the literature shows, and the distinction is not a technicality — it inverts the compound's entire significance. Beta-caryophyllene is a SELECTIVE CB2 agonist with negligible activity at CB1. This is exactly why it is non-psychoactive and exactly why it is legal as a food flavouring: CB1 is the receptor whose activation in the central nervous system produces intoxication, and beta-caryophyllene does not engage it. A CB1 ligand in the spice cabinet would be a very different regulatory object. The popular claim that beta-caryophyllene hits CB1 is common — it appears in blog posts, dispensary copy and secondary summaries — and it is mistaken; the primary source, Gertsch 2008 in PNAS, reports the selectivity explicitly. The operator notes are right about the two conclusions that follow from the correct mechanism — that it is not structurally similar to THC, and that it holds food-additive status — and the mechanism itself simply needs to be restated as CB2.

• Claim in the archive: attaches to CB1. Status: incorrect.
• Literature: selective CB2 full agonist, low nanomolar affinity at CB2, no meaningful CB1 activity (Gertsch 2008, PNAS).
• Consequence: non-psychoactive, which is why the GRAS flavouring status and the archive's "not similar to THC in structure" observation both hold.

Sources: Gertsch J 2008 · marsresident / Van Kush Family (operator) 2016*

CORRECTION to the operator archive: the detection-dog compound is caryophyllene oxide

The archive states that caryophyllene is "what dogs are trained to smell for marijuana detection". The compound named in the literature for that role is caryophyllene oxide — the epoxide of beta-caryophyllene — not beta-caryophyllene itself. Russo's 2011 review identifies caryophyllene oxide as the component characteristic of the cannabis odour signature used in canine detection. The two are distinct analytes with distinct chromatographic behaviour, and a terpene panel that reports beta-caryophyllene does not necessarily report caryophyllene oxide. The underlying point in the archive is sound; the compound identity needs one word added.

Sources: Russo EB 2011 · marsresident / Van Kush Family (operator) 2016*

CORRECTION, partial: GRAS is not FDA approval of a cannabinoid

The archive calls beta-caryophyllene the "first cannabinoid approved as food additive by FDA". The substance of this is right and the framing needs care. Beta-caryophyllene holds GRAS status as a flavouring substance in the United States and is in long-standing food and fragrance use. GRAS is a determination that a substance is generally recognised as safe for its intended use — it is not an FDA approval of a drug, and it certainly was not granted in recognition of any cannabinoid activity: the flavouring status long predates the 2008 CB2 finding. The accurate sentence is that beta-caryophyllene is a compound with GRAS flavouring status that was LATER shown to be a cannabinoid-receptor agonist, which is a more interesting fact than the one the archive states. It is also not an approval that transfers to anything else; nothing about beta-caryophyllene's status says anything about the status of any other cannabinoid.

Sources: Gertsch J 2008 · marsresident / Van Kush Family (operator) 2016*

Other documented activity contested animal

Beyond CB2, beta-caryophyllene has a broad anti-inflammatory profile documented in animal models. Fernandes and colleagues isolated alpha-humulene and (-)-trans-caryophyllene from Cordia verbenacea oil and reported anti-inflammatory effects for both in rodent models, including inhibition of oedema and of inflammatory mediator release. The operator's Temple Pharmacopoeia also lists beta-caryophyllene among natural monoacylglycerol-lipase-relevant compounds in its endocannabinoid framework; that placement should be read as a system-level grouping rather than as a demonstrated MAGL inhibition constant, and the MAGL shelf treats the enzyme-inhibitor evidence directly. Orally, beta-caryophyllene is unusual among terpenes in being systemically available after ingestion, which is what makes a dietary CB2 strategy coherent at all — most volatile terpenes are extensively metabolised or simply not absorbed in meaningful quantity.

Contested — caveat. The MAGL association is a framework grouping in the operator document, not a published inhibition constant for beta-caryophyllene. Treat CB2 agonism as the established mechanism and other enzyme-level claims as unestablished for this compound.

Sources: Gertsch J 2008 · Fernandes ES 2007 · Van Kush Family Research Institute (operator) 2026*

Where beta-caryophyllene actually is, and at what percent contested

Beta-caryophyllene is the unifying compound across the operator's botanical inventory and across a very large part of the culinary spice cabinet. The figures below are percentages of the volatile fraction unless the basis column says otherwise, and the ranges are wide because pepper and clove chemotypes vary as much as cannabis chemovars do.

Contested — caveat. Chemotype ranges, mostly single-source or operator-compiled. The black-pepper 7 to 35 percent range and the copaiba figure come from the operator document; published pepper oil analyses span at least that range and sometimes wider. The Uziza claim is an operator observation without a quantitative analysis attached.

Sources: Van Kush Family Research Institute (operator) 2026* · marsresident / Van Kush Family (operator) 2016* · Lourens ACU 2008 · Russo EB 2011 · Booth JK 2019

Industry notes

For a formulator, beta-caryophyllene is the terpene to reach for when the goal is a CB2-directed effect without cannabis and without intoxication, and it is robust enough to survive warm processing that would strip monoterpenes. For a lab tech, watch the oxide: a sample with a high caryophyllene-oxide-to-caryophyllene ratio has been exposed to air, heat or time, and that ratio is a useful freshness indicator even though it is rarely reported as such. For a buyer, beta-caryophyllene content is one of the few terpene numbers on a certificate of analysis that maps onto a mechanism with a real receptor behind it, which makes it worth more attention than the total-terpene headline figure.

Sources: Gertsch J 2008 · Russo EB 2011